Page 6 - 《中国药房》2025年18期

Pharmaceutical care for a ulcerative colitis and ankylosing spondylitis patient who developed pustular psoriasis
induced by infliximab ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ TUO Xiaoling，WANG Zhao，JU Shijie，YANG Shaoqi，MA Lijuan （2312）
Pharmaceutical care for toxic epidermal necrolysis in patients with deep vein thrombosis and acute renal insuffi-
ciency induced by warfarin ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ SHI Chao，SHU Dezhong （2317）
Immune checkpoint inhibitors combined with neoadjuvant chemotherapy and adjuvant chemotherapy in the

treatment of early-stage triple-negative breast cancer： a meta-analysis ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ YANG Chunyan，ZHANG Shaohua，LI Rongkang，PENG Lei，ZHAO Li，BIE Jun （2322）

Evidence-based study on postoperative chemotherapy guidelines/consensuses for ovarian epithelial tumor ⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ LUO Xiandan，LU Yanli，
WU Yihang，GUO Yanxiang，YAN Xiaoyi，HUO Yongchao，YAN Hui，YANG Zhenjiang，ZHANG Hongliang （2328）
Research progress on the mechanisms of traditional Chinese medicine regulating NLRP3 inflammasome to
intervene in renal fibrosis ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ HUANG Chenjie，YUAN Wenqi，LU Yaohong，YAN Ziyou （2334）
Research progress on the mechanism of traditional Chinese medicine monomers acting on myelosuppression after

chemotherapy based on the four properties theory ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
ZHANG Sihan，WANG Tingting，ZHAO Zhifen，KANG Hanyu，JI Jiaqi，GUO Ziqiang，LIU Tong，JIANG Shiqing （2341）
Research progress on the chemical constituents， pharmacological mechanisms and clinical application of Jiegeng
decoction ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ HUANG Yun，HUANG Shunwang，
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ QIAO Jinwei，XU Qian，GAO Xiaoming，BAO Xuemei，YANG Manqin，XIE Ruonan，CAI Ming （2348）

CHINA PHARMACY （Semimonthly） Postal Address
Founded in January 1990 Journal Center of Chongqing University Cancer Hospital
Vol.36， No.18， Sept. 2025 129 Daping Main Street，Yuzhong District，Chongqing
Total No.804 Published on Sept. 30，2025 400042，China
Phone
Responsible Institution +86-23-63830521；+86-23-63830907；+86-23-68586727；
National Health Commission，P.R. China +86-23-68586827；+86-23-68573988
Sponsored by E-mail
info@china-pharmacy.com
Chinese Hospital Association Website
Chongqing University Cancer Hospital http：//www.china-pharmacy.com
Published by Online Submission
China Pharmacy Editorial Department http：//user.china-pharmacy.com
Director of Editorial Commission Printed by
TIAN Jiazheng Chongqing Changhong Printing Co.， Ltd.
Executive Deputy Director of Editorial Commission Distributed by
WU Yongzhong China： Chongqing Branch of China Post Group Co.， Ltd.
Deputy Director of Editorial Commission （Code No.78-33）
WANG Ying Overseas： China International Book Trading Corporation
Chief of Journal Center （Code No.4703SM）
Subscription Rates
ZOU Xiaoyong CNY 15 per issue；CNY 360 per annum
Editor-in-Chief ISSN 1001-0408
HU Xin CSSN CN 50-1055/R
Deputy Editor-in-Chief CODEN
LENG Huaiming；ZOU Xiaoyong ZYHAA4
Chief Editor Perennial Legal Counsel
ZHANG Jian Chongqing Huali Wantao Law Firm